Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Core Laboratories Q2 EPS $0.21 Beats $0.20 Estimate, Sales $127.88M Miss $131.46M Estimate

Author: Bill Haddad | July 26, 2023 05:26pm
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.20 by 5 percent. This is a 75 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $127.88 million which missed the analyst consensus estimate of $131.46 million by 2.72 percent. This is a 5.78 percent increase over sales of $120.90 million the same period last year.

Posted In: CLB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist